What Matters Most: The Three Trends That Will Change Pharma Marketing in 2025
This year’s EVERSANA INTOUCH annual trends forecast – our ninth! – is both smaller and bigger than those that have come before it. Technology (No. 1: applied AI) is enabling entirely new ways to do business (No. 2: the direct-to-patient model) in a paradigm that’s interconnected (No. 3: globalization and health equity) at every level. […]
Read More
More Industry Blogs
03|20|25
SXSW 2025: A Mandate, A Path, A Tool
At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers. But it's also the most rewarding challenge, and one that has sharpened our superpowers .In this POV, we discuss how we can harness these opportunities to navigate the challenges ahead.
03|18|25
The Digital Determinants of Health: Shaping the Future of Well-Being
Download the POV, The Digital Determinants of Health, to discover how understanding digital determinants of health can transform pharmaceutical strategies and drive business success.
03|13|25
AI With A Human Touch: Ensuring Authenticity in AI Marketing
In this POV, Morgan Hartzell, VP, Client Services, explores several key strategies to ensure marketing remains genuine and trustworthy, while still leveraging the benefits of AI technology.
03|07|25
Redefining Loyalty: The Role of Decentralized Healthcare and Data Ownership
This POV explores how decentralized healthcare models and data ownership are transforming patient loyalty, and highlights strategies to foster loyalty in this new landscape. Download the POV to learn more.
02|28|25
Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave
Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.
02|28|25
Rare but Prevalent: The Unequal Toll of Rare Diseases on Women
Learn how pharmaceutical companies can address gaps in women's health related to rare disease, and improve outcomes for patients.
02|25|25
Bringing Creative Excellence to Pre-Flight Safety Videos: Insights From Ivan Blotta
EVERSANA INTOUCH's Head of Art and Creative Excellence shares three key elements that bring creative excellence into pharma marketing.
02|20|25
Building Trust With Education and Innovation: Rare Disease Marketing
Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months. […]
02|10|25
Next-Generation Brand Planning: (Unexpected) Worrying Trends Demand a Rethink on Brand Planning
In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.
02|06|25
Pharma Marketing and the Super Bowl: A Missed Opportunity?
During the Super Bowl, is when we see some of the most entertaining and memorable commercials. However, pharmaceutical companies often remain on the sidelines during this prime advertising opportunity. In a recent article in MM+M, pharma industry thought leaders, including John Kenny, Chief Strategy Officer, and Susan Perlbachs, Chief Creative Officer, offer their insights as to why pharma brands are hesitant to invest in Super Bowl ads despite the massive audience.